BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 24/09/2010

NIH Seeks Exclusive License for Chikungunya Treatment

The National Institutes of Health is considering granting an exclusive license to Merck Sharp & Dohme Corp. to develop, manufacture, and sell treatments for Chikungunya infections, in accordance with US patent laws.

Source: Federal Register — Health and Human ServicesOpen original release →